In Vitro and Ex Vivo Evaluation of Rifampicin Cytotoxicity in Human Skin Models
Antibiotics · 08.07.2025 · 14 (7) · 691
DOI: 10.3390/antibiotics14070691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 08.07.2025. Verfasst von Marcel Nani Leite und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, São Paulo…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background/Objectives: Drugs for human use require several studies for the assessment of their efficacy and safety. An important property is cytotoxicity, which should be tested in different environments and models in closer proximity to the final use of the drug, with greater reliability. Thus, we proposed to evaluate the toxicity of rifampicin, the only bactericidal drug in the anti-leprosy multidrug therapy, using skin cells and skin explant cultures.
Methods
Cell viability was tested by the MTT method using primary keratinocytes and fibroblasts and immortalized skin cells (HaCaT and 3T3) at 24, 48, and 72 h of treatment. For the skin explant, we used the TTC assay to determine viability (24, 48, 72, and 96 h), hematoxylin and eosin staining to analyze the structure and architecture of the tissue, and TUNEL to assess apoptotic cells at 3, 6, 12, 24, 48, 72, and 96 h.
Results
Regarding the toxicity of primary and immortalized cells, viability was above 70% up to a concentration of 50 μg/mL at 24, 48, and 72 h, and at the concentration of 200 μg/mL, all cells showed greater sensitivity, especially at 72 h. Tissue viability analysis revealed a high percentage (above 96%) of viable tissue at the concentrations of 100, 150, and 200 μg/mL at the time points studied. Histological analysis showed that tissue architecture was maintained, with no apoptotic cells being observed.
Conclusions
Thus, our results showed the importance of evaluating drug toxicity using different cell types, with the ex vivo skin model proving to be an alternative to animal use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, São Paulo, Brazil.
- Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, São Paulo, Brazil.
ORCID-Profile: Natália Aparecida de Paula, Marco Andrey Cipriani Frade
Förderung
- National Council for Scientific and Technological Development
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP (FAEPA)
Zitieren
APA
Leite, M. N., de Paula, N. A., Ramalho, L. N. Z., & Frade, M. A. C. (2025). In Vitro and Ex Vivo Evaluation of Rifampicin Cytotoxicity in Human Skin Models. Antibiotics, 14(7), 691. https://doi.org/10.3390/antibiotics14070691
Vancouver
Leite MN, de Paula NA, Ramalho LNZ, Frade MAC. In Vitro and Ex Vivo Evaluation of Rifampicin Cytotoxicity in Human Skin Models. Antibiotics. 2025;14(7):691. doi:10.3390/antibiotics14070691
BibTeX
@article{Leite2025,
author = {Leite, Marcel Nani and de Paula, Natália Aparecida and Ramalho, Leandra Náira Zambelli and Frade, Marco Andrey Cipriani},
title = {In Vitro and Ex Vivo Evaluation of Rifampicin Cytotoxicity in Human Skin Models},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {7},
pages = {691},
doi = {10.3390/antibiotics14070691}
}
EUVIMED